Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.24
-0.0100-0.44%
Post-market: 2.240.00000.00%18:48 EDT
Volume:67.95K
Turnover:154.00K
Market Cap:64.65M
PE:-1.45
High:2.34
Open:2.22
Low:2.22
Close:2.25
Loading ...
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2022

Major Issues Report

8-K - Current report
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]